Summary Mammary epithelial cells (MECs) were isolated and cultured from mammary glands of healthy women undergoing reduction mammoplasty. Normal MECs were infected with the transforming hybrid virus adeno-5/SV40. Two transformed epithelial cell lines, Ml and M2, were obtained, characterised phenotypically and studied for the production of and the response to cytokines and growth regulators. In both cell lines, expression of the SV40 large T antigen was associated with loss of interleukin 6 (IL-6) production and responsiveness as well as with down-regulation of IL-8 and transforming growth factor (TGF)-a production. Both Ml and M2 cell lines were capable of forming colonies in semisolid media, but upon injection into severe combined immunodeficient (SCID) mice only M2 cells were tumorigenic. DNA synthesis in Ml cells was partially inhibited by serum or TNF-ac and weakly stimulated by hydrocortisone (HC) and IL-8. In contrast, M2 cells were totally unresponsive to a variety of growth regulators. Both lines overexpressed the p53 protein at levels about 20-fold higher than those observed in primary MEC cultures, but no mutations of the p53 gene could be detected. The data confirm the view that the expression in human mammary cells of different oncogenes -including the SV40 T antigen -is frequently associated with alterations of cytokine production and responsiveness.
This study was initiated to investigate in vitro the early phenotypic alterations associated with the transforming activity of simian virus 40 (SV40) in human mammary epithelial cells (MECs) obtained from healthy donors. Several human breast cancer cell lines have already been obtained in different laboratories (O'Hire, 1991) , but only a few human MEC lines have been derived from normal breast tissue (Soule et al., 1990; Paine et al., 1992) . Owing to the extremely low frequency of spontaneous immortalisation, MEC lines have been established either by chemical treatment, by transfection with different oncogenes or by infection with oncogenic viruses (Calaf and Russo, 1993; Ciardiello et al., 1993; Ochieng et al., 1991; Berthon et al., 1992) . We used a replication-defective recombinant adeno-5/SV40 virus (Ad5/SV40) that carries the adenovirus type 5 capsid, the early genomic adenovirus region lacking the origin of replication, and the SV40 large T antigen (SV40 T Ag; Van Doren and Gluzman, 1984) . Primary MEC cultures obtained from healthy donors undergoing reduction mammoplasty were infected with this transforming virus. The SV40 T Ag, which forms stable complexes with tumoursuppressor gene products p53 and Rb (Ludlow, 1993) , appears to produce alterations of cytokine pathways similar to those observed in the neoplastic transformation of MECs by other oncogenes (Basolo et al., 1993a,b) . Of the two Ad5/SV40-immortalised MEC lines that were characterized, only one was tumorigenic when injected into immunodeficient mice. However, transformation of MECs by SV40 T Ag was consistently associated with changes in interleukin 6 (IL-6) expression and responsiveness. Materials prepared by mechanic and collagenase dissociation and cultured in Dulbecco's modified Eagle medium (DMEM)/ F12 low-calcium medium (0.04 mM Ca2+) supplemented with insulin (5 jug ml-'), hydrocortisone (HC; 500 ng ml-'), human recombinant epidermal growth factor (EGF; 10 ng ml-'), cholera toxin (100 ng ml-') and 5% horse serum, according to Soule's method (Soule et al., 1990) . Tissue culture reagents were from Sigma, (St. Louis, MO, USA). Pure MEC cultures were infected between 40 and 55 days post plating with a replication-incompetent ori-hybrid Ad5/SV40 virus (R4 strain; Van Doren and Gluzman, 1984) and grown in complete medium with standard calcium concentration (1.05 mM Ca2+; high-calcium medium, HCM). After 20-25 days, colonies of transformed cells were picked up with the help of glass cylinders and expanded. MECs that were capable of growing over at least 15 passages and that were capable of forming colonies in semisolid media were considered transformed and further characterised. Two MEC lines originated from different donors (designated Ml and M2) were analysed in detail. Serum-free medium (SFM) was used to evaluate the response of MECs to growth regulators. SFM consisted of DMEM/F12 with 1.05 mM Ca2 , 0.3% dialysed fetal bovine serum (FBS), 0.2% bovine serum albumin (BSA), human-transferrin (5 ig ml-1), sodium-selenite (5 ng ml-') and insulin (10 jug ml-'). Primary MEC cultures, the spontaneously immortalised MCF-1OA normal breast cell line (Soule et al., 1990 ) and the breast carcinoma-derived T47D cell line were used as controls.
Immunocytochemistry and immunoradiometric assay For immunocytochemical staining, cells were grown in chamber slides (Nunc, Naperville, IL, USA) and fixed in 1:1 (v/v) 
Measurement of cytokine levels
Conditioned media from both primary cultures and Ad5/ SV40-infected cell lines were used to measure the release of IL-1-ax and -/3, IL-6, IL-8 and TGF-a with immunoenzyme assays [dosage kits were from: Genzyme, Boston, MA, USA (IL-1-cx; sensitivity 5 pg ml-1; IL-I-fl, sensitivity 1 pg ml-1), R&D Systems, Minneapolis, MN, USA (IL-6, sensitivity 5 pg ml-'; IL-8, sensitivity 30 pg ml-'), Oncogene Science (TGF-a, sensitivity 25 pg ml-1)]. Samples were taken 3, 6 and 9 days after plating (reported data refer to day 6).
Analysis of cytokine transcripts Cytokine-specific mRNAs were detected in total RNA extracted from 106 cells by the guanidinium thiocyanate method. After treatment with RNAase-free DNAase for 1 h at 37°C, cDNA was obtained by using M-MLV reverse transcriptase in conjunction with random hexamer primers (Clontech, Palo Alto, CA, USA). cDNA was then amplified by the polymerase chain reaction (PCR) using Taq polymerase and cytokine-specific primer pairs (Cytokine MAPPing Amplimers, Clontech). Amplification was carried out for the following human transcripts: IL-6 (amplified products 628 bp), IL-8 (amplified product 289 bp), TGF-a (amplified product 297 bp) and ,B-actin (amplified product 1126 bp). ,B-Actin was used as a control for mRNA detectability. Thirty Anchorage-independent growth and Matrigel colonisation assay For colony-formation in soft agar and methylcellulose, 2 x 104 cells were suspended in 0.5 ml of HCM supplemented with either 0.3% Agar Noble (Difco, Detroit, MI, USA) or 0.8% carboxymethylcellulose (Sigma) and layered on a 0.8% Agar Noble base (0.25 ml in 2 cm2 wells). Twenty-one days post plating, colonies > 60 ,um in diameter were photographed and counted.
The Matrigel colonisation assay was performed as described previously (Albini, 1989) . Matrigel (0.5 ml at 10 mg ml-'; Collaborative Research, Bedford, MA, USA) was polymerised at 370C for 1 h in wells of a 24-well plate. Cells suspended in HCM were seeded at 5 x 104 onto the top of the gel. After 1, 2 and 3 weeks incubation, cultures were observed for morphology and photographed. lines were tested for their ability to differentiate in Matrigel. Three weeks after plating, the spontaneously immortalised MCF-IOA cell line formed only small colonies in Matrigel (i.e. <50 gim in diameter; Figure 2a ). In contrast, Ml cells were able to differentiate into duct-like structures, whereas M2 cells formed large colonies (Figure 2b and 2c ).
p53 protein expression It is known that the p53 protein is frequently mutated in breast tumours and that it is stabilised by the SV40 T Ag. To investigate the possible role of p53 alterations in producing the transformed phenotype of AdS/SV40-infected cells, we studied the expression of p53 in MI and M2 using three different MAbs. MAbs 1801 and DOI (reacting with both wild-type and mutant forms of p53) stained over 80% of nuclei of Ml and M2 cells, but failed to stain normal cells Enzyme-linked immunoassays capable of detecting either the wild-type p53 plus its mutant forms or the mutant forms alone were used to measure the levels of p53 produced by Ml and M2 cells (Table III) . Primary cultures of normal MECs and the T47D mammary carcinoma cell line carrying a mutant form of p53 were used as controls. Measurable levels of wild-type p53 were detected both in cell extracts and in the supernatant of all test cultures, while 'mutant' forms of p53 were detected only in cultures of transformed lines.
Taken together, the above data indicated that changes in p53 expression had occurred in SV40-transformed lines.
Analysis of p53 mutations
To understand if the altered forms of p53 found in AdS/ SV40-infected cells were due to sequence mutations or to conformational changes, hotspot p53 exons 5-9 were analysed by PCR-single-strand conformation polymorphism (SSCP Yilmaz et al., 1993) .
In spite of the absence of detectable mutations, transformed lines overexpressed wild-type and/or 'mutant' forms of p53 at levels about 20-fold higher than normal MECs. The following observations may help explain the data: (a) the p53 protein has a longer half-life in MEC than in human fibroblasts (3 h vs 30 min; Delmolino et al., 1993); (b) p53 is complexed by the SV40 T Ag and accumulates in infected cells (Bartek et al., 1993; Chang et al., 1993) . The latter mechanism may account for the high levels of 'mutant' p53 found by immunological methods. In fact, complexing of p53 with SV40 T Ag may produce conformational changes of the target that could make it reactive with the antibody 'specific' for mutant forms. ELISA showed that tumorigenic and non-tumorigenic cells produced equivalent amounts of 'mutant' p53, but the tumorigenic M2 cell line did not release the protein extracellularly. In agreement with that, staining of M2 cells with antibodies to either SV40 T Ag or p53 produced patterns more intense than those seen in Ml cells.
Normal MECs have the capacity of producing several different cytokines. Consistent with what was observed in the case of MECs transformed by various oncogenes (c-Ha-ras, c-erb-B2, int-2; Basolo et al., 1993b), the secretion of some cytokines (IL-8, TGF-a) was reduced, while that of IL-6 was abolished. Moreover, both SV40-transformed MEC lines were unable to respond to both and TGF-/.
Tumorigenic M2 cells were also totally unresponsive to a variety of growth regulators (HC, EGF, horse serum, IL-8, TNF-a). Non-tumorigenic Ml cells had an intermediate phenotype and formed duct-like structures when grown in Matrigel, i.e. retained some degree of differentiation (Shearer et al., 1992; Petersen et al., 1992) . In contrast, M2 cells produced mainly large colonies and induced tumours in SCID mice. Unresponsiveness to TGF-,B -an important regulator of normal and neoplastic cells (Derynk, 1994; Emerman and Eaves, 1994 ) -has been observed in other experimental models (Reiss et al., 1993; Basolo et al., 1994; Herman and Katzenellenbogen, 1994) . Taken together, the data confirm the hypothesis that alterations of and TGF-3 pathways represent an early and common event in mammary carcinogenesis (Basolo et al., 1993a, b and 1994) .
Our results appear to confirm that the expression of the SV40 T Ag gene in breast epithelial cells may directly cause Cytok-ai manuny cds trumssormed by Ad5/SV40 viru F Basolo et ai 1361 the appearance of a malignant phenotype (Berthon et al., 1992) . The phenotypic differences between non-tumorigenic Ml and tumorigenic M2 cells are, however, unclear and not due to detectable p53 mutations. How transformation by SV40 is linked to the above events and, particularly, to alterations of IL-6 production and responsiveness remains to be elucidated.
